284 related articles for article (PubMed ID: 36074476)
21. Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study.
Netuka I; Ivák P; Tučanová Z; Gregor S; Szárszoi O; Sood P; Crandall D; Rimsans J; Connors JM; Mehra MR
J Heart Lung Transplant; 2018 May; 37(5):579-586. PubMed ID: 29655662
[TBL] [Abstract][Full Text] [Related]
22. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?
Florisson DS; Conte SM; De Bono JA; Newcomb AE
Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.
Colombo PC; Mehra MR; Goldstein DJ; Estep JD; Salerno C; Jorde UP; Cowger JA; Cleveland JC; Uriel N; Sayer G; Skipper ER; Downey FX; Ono M; Hooker R; Anyanwu AC; Givertz MM; Mahr C; Topuria I; Somo SI; Crandall DL; Horstmanshof DA
Circulation; 2019 Jan; 139(2):155-168. PubMed ID: 30586698
[TBL] [Abstract][Full Text] [Related]
24. Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure.
Rogers JG; Pagani FD; Tatooles AJ; Bhat G; Slaughter MS; Birks EJ; Boyce SW; Najjar SS; Jeevanandam V; Anderson AS; Gregoric ID; Mallidi H; Leadley K; Aaronson KD; Frazier OH; Milano CA
N Engl J Med; 2017 Feb; 376(5):451-460. PubMed ID: 28146651
[TBL] [Abstract][Full Text] [Related]
25. Incidence and clinical correlates of de-novo aortic regurgitation with a fully magnetically levitated left ventricular assist device: a MOMENTUM 3 trial portfolio analysis.
Uriel N; Milano C; Agarwal R; Lee S; Cleveland J; Goldstein D; Wang A; Crandall D; Mehra MR
Eur J Heart Fail; 2023 Feb; 25(2):286-294. PubMed ID: 36404406
[TBL] [Abstract][Full Text] [Related]
26. Evolving trends in mechanical circulatory support: Clinical development of a fully magnetically levitated durable ventricular assist device.
Sidhu K; Lam PH; Mehra MR
Trends Cardiovasc Med; 2020 May; 30(4):223-229. PubMed ID: 31201005
[TBL] [Abstract][Full Text] [Related]
27. Short-Term Outcomes of Magnetically Levitated Left Ventricular Assist Device in Advanced Heart Failure - The Japanese Cohort.
Inoue K; Fujita T; Yoshioka D; Tonai K; Yanagino Y; Kakuta T; Tadokoro N; Kawamoto N; Yamashita K; Kawamura A; Matsuura R; Kawamura T; Saito T; Kawamura M; Kainuma S; Fukushima S; Toda K; Miyagawa S
Circ J; 2022 Nov; 86(12):1961-1967. PubMed ID: 36273915
[TBL] [Abstract][Full Text] [Related]
28. Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial.
Yau TM; Pagani FD; Mancini DM; Chang HL; Lala A; Woo YJ; Acker MA; Selzman CH; Soltesz EG; Kern JA; Maltais S; Charbonneau E; Pan S; Marks ME; Moquete EG; O'Sullivan KL; Taddei-Peters WC; McGowan LK; Green C; Rose EA; Jeffries N; Parides MK; Weisel RD; Miller MA; Hung J; O'Gara PT; Moskowitz AJ; Gelijns AC; Bagiella E; Milano CA;
JAMA; 2019 Mar; 321(12):1176-1186. PubMed ID: 30912838
[TBL] [Abstract][Full Text] [Related]
29. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
30. Third Annual Report From the ISHLT Mechanically Assisted Circulatory Support Registry: A comparison of centrifugal and axial continuous-flow left ventricular assist devices.
Goldstein DJ; Meyns B; Xie R; Cowger J; Pettit S; Nakatani T; Netuka I; Shaw S; Yanase M; Kirklin JK
J Heart Lung Transplant; 2019 Apr; 38(4):352-363. PubMed ID: 30945637
[TBL] [Abstract][Full Text] [Related]
31. Using left ventricular assist devices in advanced heart failure patients.
Shah SR; Issa Najim N; Shah SA; Shahnawaz W; Ahmed Jangda M
J Community Hosp Intern Med Perspect; 2018; 8(6):357-359. PubMed ID: 30559944
[TBL] [Abstract][Full Text] [Related]
32. Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: An analysis from the MOMENTUM 3 study.
Saeed O; Colombo PC; Mehra MR; Uriel N; Goldstein DJ; Cleveland J; Connors JM; Najjar SS; Mokadam NA; Bansal A; Crandall DL; Sood P; Jorde UP
J Heart Lung Transplant; 2020 Jun; 39(6):518-525. PubMed ID: 32340871
[TBL] [Abstract][Full Text] [Related]
33. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
34. Quantifying the impact from stroke during support with continuous flow ventricular assist devices: An STS INTERMACS analysis.
Kirklin JK; Naftel DC; Myers SL; Pagani FD; Colombo PC
J Heart Lung Transplant; 2020 Aug; 39(8):782-794. PubMed ID: 32376278
[TBL] [Abstract][Full Text] [Related]
35. Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device.
Nayak A; Hall SA; Uriel N; Goldstein DJ; Cleveland JC; Cowger JA; Salerno CT; Naka Y; Horstmanshof D; Crandall D; Wang A; Mehra MR
J Am Coll Cardiol; 2023 Aug; 82(9):771-781. PubMed ID: 37612008
[TBL] [Abstract][Full Text] [Related]
36. Lessons learned from the first fully magnetically levitated centrifugal LVAD trial in the United States: the DuraHeart trial.
Moazami N; Steffen RJ; Naka Y; Jorde U; Bailey S; Murali S; Camacho MT; Zucker M; Marascalco PJ; Rao V; Feldman D;
Ann Thorac Surg; 2014 Aug; 98(2):541-7. PubMed ID: 24928670
[TBL] [Abstract][Full Text] [Related]
37. LVAD decommissioning for myocardial recovery: Long-term ventricular remodeling and adverse events.
Gerhard EF; Wang L; Singh R; Schueler S; Genovese LD; Woods A; Tang D; Smith NR; Psotka MA; Tovey S; Desai SS; Jakovljevic DG; MacGowan GA; Shah P
J Heart Lung Transplant; 2021 Dec; 40(12):1560-1570. PubMed ID: 34479776
[TBL] [Abstract][Full Text] [Related]
38. A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective.
Lim HS; Shaw S; Carter AW; Jayawardana S; Mossialos E; Mehra MR
J Heart Lung Transplant; 2022 Feb; 41(2):174-186. PubMed ID: 34922821
[TBL] [Abstract][Full Text] [Related]
39. Can we expect improvements in outcomes with centrifugal vs axial flow left ventricular assist devices in patients transitioned from extracorporeal life support?
Urban M; Siddique A; Moulton MM; Castleberry AW; Merritt-Genore H; Ryan T; Lowes B; Um JY
J Card Surg; 2019 Nov; 34(11):1228-1234. PubMed ID: 31478259
[TBL] [Abstract][Full Text] [Related]
40. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
